JUBILANT PHARMOVA LIMITED (JUBLPHARMA)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 199.84 217.40 186.30 175.20 205.80 166.70 165.70 196.00 217.30 59.50 66.40 67.30
YOY Revenue Growth % 594.13% 8.68% -16.45% -4.13% 2.98% -23.32% -11.06% 11.87% 5.59% -64.31% -59.93% -65.66%
Other Income 13.66 15.90 18.40 19.00 50.10 19.50 43.80 18.40 17.90 0.70 0.80 0.40
Total Income 213.50 233.30 204.70 194.20 255.90 186.20 209.50 214.40 235.20 60.20 67.20 67.70
Total Expenses + 187.31 179.40 194.30 173.20 175.80 170.50 175.60 185.60 211.70 53.70 58.70 57.60
Cost of Materials Consumed 90.39 71.90 94.90 69.10 74.10 65.50 62.20 76.80 78.00 0.00 0.00 0.00
Employee Benefit Expense 40.07 47.50 46.10 49.90 46.50 48.70 51.40 52.10 50.80 23.20 26.60 29.20
Other Expenses 56.85 60.00 53.30 54.20 55.20 56.30 62.00 56.70 59.80 26.00 28.00 25.90
Operating Profit 12.53 38.00 -8.00 2.00 30.00 -3.80 -9.90 10.40 5.60 5.80 7.70 9.70
OPM % 6.3% 17.5% -4.3% 1.1% 14.6% -2.3% -6% 5.3% 2.6% 9.7% 11.6% 14.4%
Profit Before Tax + -1.23 2.30 0.20 -2.30 41.50 -11.20 16.60 8.70 23.50 6.50 8.50 10.10
Tax Expense 29.63 0.40 0.60 0.10 9.00 -1.00 6.10 3.40 9.90 0.70 14.90 3.50
Tax % - 17.4% 300% - 21.7% - 36.7% 39.1% 42.1% 10.8% 175.3% 34.7%
Profit After Tax -30.86 1.90 -0.40 -2.40 32.50 -10.20 10.50 5.30 13.60 5.80 -6.40 6.60
EPS (Basic) -1.94 0.12 -0.03 -0.15 2.05 -0.64 0.66 0.33 0.86 0.36 -0.40 0.42

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 745.70 784.70 810.12 87.75 2,709.50
YOY Revenue Growth % -4.97% -3.14% 823.21% -96.76% -
Other Income 99.60 103.40 137.89 125.87 47.88
Total Income 845.30 888.10 948.01 213.62 2,757.38
Total Expenses + 796.50 722.70 788.64 94.53 2,161.00
Cost of Materials Consumed 282.50 310.00 396.30 0.00 1,328.92
Employee Benefit Expense 203.00 190.00 167.27 49.21 220.67
Other Expenses 234.80 222.70 225.07 45.32 611.41
Operating Profit -50.80 62.00 21.48 -6.78 548.50
OPM % -6.8% 7.9% 2.7% -7.7% 20.2%
Profit Before Exceptional 48.80 41.70 79.34 82.25 273.17
Exceptional Items -11.20 0.00 0.00 0.00 0.00
Profit Before Tax + 37.60 41.70 79.34 82.25 273.17
Tax Expense 18.40 10.10 29.46 3.75 58.69
Tax % 48.9% 24.2% 37.1% 4.6% 21.5%
Profit After Tax 19.20 31.60 49.88 78.50 214.48
EPS (Basic) 1.21 1.99 3.13 4.93 13.47

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 2,425.40 2,451.30 2,429.59 0.00 0.00
Property, Plant & Equipment 514.80 522.60 491.48 0.00 0.00
Capital Work in Progress 19.30 37.00 46.97 0.00 0.00
Non-Current Investments 1,657.00 1,656.90 1,656.56 0.00 0.00
Goodwill 137.10 137.10 137.13 0.00 0.00
Other Intangible Assets 5.40 1.80 58.79 0.00 0.00
Current Assets + 484.20 540.60 578.88 0.00 0.00
Inventories 232.40 250.90 313.60 0.00 0.00
Trade Receivables 206.30 194.20 188.52 0.00 0.00
Cash and Cash Equivalents 12.60 36.10 10.99 0.00 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 15.90 15.90 15.93 0.00 0.00
Other Equity 2,302.20 2,358.60 2,398.62 0.00 0.00
Non-Current Liabilities 281.20 302.00 232.73 0.00 0.00
Current Liabilities 310.30 315.40 361.19 0.00 0.00
Total Liabilities 591.50 617.40 593.92 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 135.60 143.20 -65.12 -6.47 0.00
Cash from Investing Activities -2.30 -40.30 31.07 96.02 0.00
Cash from Financing Activities -156.80 -77.80 22.51 -107.37 0.00
Net Increase/Decrease in Cash -23.50 25.10 -11.54 -17.82 0.00